Barely Significant
← all excerpts

Comparative Analysis of a Dual DNA-RNA Panel and a DNA-Only Panel for Sarcoma: Real-World Data From a Nationwide Genomic Database.

Cancer Sci · 2026 · PMC12775561 · PMID 41128349

Europe PMCDOI
1
hedged sentence
0.2500
closest p · 5.0× alpha
0.2500
boldest claim

The sentences

showed a trendp = 0.25not close (p > 0.1)
In non‐gastrointestinal stromal tumor sarcomas, the dual test showed a trend toward higher rates of genotype‐matched therapy (4.3% vs. 2.6%, p = 0.25) and a significantly higher rate of molecular targeted therapy (4.3% vs. 1.5%, p = 0.03).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.